VIA
CELL

Vident Investment Advisory’s PhenomeX Inc. Common Stock CELL Stock Holding History

Vident Investment Advisory’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,510
Closed -$10.1K – 1162
2023
Q2 		$10.1K Sell
20,510
-3,845
-16% -$3.15K ﹤0.01% 1172
2023
Q1 		$28.3K Buy
+24,355
New +$44.5K ﹤0.01% 1219

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vident Investment Advisory's CELL Position: Q3 2023 in Review

Vident Investment Advisory sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 20,510 shares — an estimated $10.1K sold.

Vident Investment Advisory first reported a position in CELL in Q1 2023 and held it in 2 quarters. The position peaked at $28.3K in Q1 2023. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Vident Investment Advisory reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 20,510 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $10.1K.
  • Vident Investment Advisory first reported a position in PhenomeX Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Vident Investment Advisory's PhenomeX Inc. Common Stock position peaked at $28.3K in Q1 2023.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.